Section Arrow
ANIK.NASDAQ
- Anika Therapeutics
Quotes are at least 15-min delayed:2026/02/10 22:37 EST
Regular Hours
Last
 10.33
+0.1 (+0.98%)
Day High 
10.62 
Prev. Close
10.23 
1-M High
10.95 
Volume 
133.29K 
Bid
9.55
Ask
12.5
Day Low
10.13 
Open
10.13 
1-M Low
9.0101 
Market Cap 
147.53M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 9.8 
20-SMA 9.61 
50-SMA 9.58 
52-W High 18.345 
52-W Low 7.8701 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.27/0.35
Enterprise Value
171.54M
Balance Sheet
Book Value Per Share
10.18
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
119.91M
Operating Revenue Per Share
11.32
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health17.24-2.09-10.81%32.4PE
VTRSViatris15.95+0.39+2.51%-- 
CGCCanopy Growth Corp1.09------ 
AKBAAkebia Therapeutics1.51+0.01+0.67%-- 
TEVATeva Pharmaceutical Industries Limited34.37-0.1-0.29%28.41PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.